RT Journal Article
SR Electronic
T1 Short-term intensive fasting improves red blood cell function and rejuvenates erythropoiesis via regulating MS4A3-CDK2 module
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.08.18.22278875
DO 10.1101/2022.08.18.22278875
A1 Xu, Li
A1 Wei, Wen
A1 Qian, Jiawei
A1 Zhang, Suping
A1 Jin, Zhicong
A1 Wang, Xueqing
A1 Li, Lei
A1 Gu, Yue
A1 Lv, Yaqi
A1 Zhao, Chen
A1 Gao, Xueqin
A1 Bu, Wenwen
A1 Zhang, Ruizhi
A1 Ma, Xiaoya
A1 Yang, Yanjun
A1 Yan, Zhanjun
A1 Chen, Yuwei
A1 Sun, Qiyuan
A1 Wang, Li
A1 Chen, Zixing
A1 Xu, Youjia
A1 Xu, Peng
A1 Zhao, Yun
A1 Fang, Yixuan
A1 Yuan, Na
A1 Wang, Jianrong
YR 2022
UL http://medrxiv.org/content/early/2022/08/22/2022.08.18.22278875.abstract
AB Fasting is known to improve health, but the precisely beneficial effects of specific types of fasting and their underlying mechanisms are not fully understood. We herein report that in humans, occasional short-term intensive fasting (STIF), a traditional fasting format favored by Asians, promotes erythropoiesis and boosts the function of red blood cells (RBCs) in oxygen transportation, ATP generation, antioxidant capacity, and innate immune response. The rejuvenation of erythropoiesis is more pronounced in humans with low RBC counts. Using mouse models and a human erythroid progenitor cell model, we found that occasional STIF rejuvenates erythropoiesis by enhancing megakaryocyte-erythroid progenitor selfrenewal and erythroid-biased differentiation without compromising normal hematopoiesis. Molecularly, STIF relies on an autophagy-dependent but erythropoietin (EPO) upregulation-independent MS4A3-CDK2 module to augment the production of RBCs. Our findings thus suggest that STIF can occasionally be practiced as an efficient noninvasive intervention for better erythropoiesis, particularly for adults with low RBC counts.In brief Xu et al showed that short-term intensive fasting (STIF), when occasionally practiced, boosts red blood cell function and promotes erythropoiesis by regulating MS4A3-CDK2 module to enhance megakaryocyte-erythroid progenitor selfrenewal and erythroid-biased differentiation.HighlightsOccasional STIF boosts the function of red blood cellsOccasional STIF promotes erythropoiesis, which is more significant in adults with low red blood cell countsOccasional STIF selectively enhances MEP selfrenewal and erythroid-biased differentiation via MS4A3-CDK2 moduleThe erythropoietic MS4A3-CDK2 response to STIF is autophagy-dependent but EPO upregulation-independent.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialChiCTR1900027451Funding StatementNational Natural Science Foundation of China by grants No.91649113, No.82170227 and No.31771640 (to JW)Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was conducted with approval from the Institutional Ethics Review Board at Soochow University (Approval No. ECSU-2019000153) and the Chinese Clinical Trial Register, an official review board for clinical trials (Registration No. ChiCTR1900027451), affiliated with The Ministry of Public Health of China (http://www.chictr.org.cn/index.aspx).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present work are contained in the manuscript